Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients?

MLA

Sun, Li-Min, et al. “Does Use of Tetracyclic Antidepressant-Mirtazapine Reduce Cancer Risk in Depression Patients?” Pharmacoepidemiology and Drug Safety, vol. 22, no. 12, Dec. 2013, pp. 1292–97. EBSCOhost, https://doi.org/10.1002/pds.3523.

APA

Sun, L.-M., Lin, M.-C., Liang, J.-A., Chang, Y.-J., Chang, S.-N., Sung, F.-C., Muo, C.-H., & Kao, C.-H. (2013). Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients? Pharmacoepidemiology and Drug Safety, 22(12), 1292–1297. https://doi.org/10.1002/pds.3523

Chicago

Sun, Li-Min, Ming-Chia Lin, Ji-An Liang, Yen-Jung Chang, Shih-Ni Chang, Fung-Chang Sung, Chih-Hsin Muo, and Chia-Hung Kao. 2013. “Does Use of Tetracyclic Antidepressant-Mirtazapine Reduce Cancer Risk in Depression Patients?” Pharmacoepidemiology and Drug Safety 22 (12): 1292–97. doi:10.1002/pds.3523.